ASOs have emerged as a critical focus in ALS research, particularly in targeting transcripts of C9orf72. This approach has shown efficacy in reducing nuclear RNA foci associated with C9orf72 in ALS, reversing abnormal gene expression, and decreasing excitotoxicity in iPSC-derived neurons. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.